Skip to main content
C

Canna 8 Investment Trust — Investor Relations & Filings

Ticker · RCR.P TSXV Financial and insurance activities
Open in API
Filings indexed 78 across all filing types
Latest filing 2025-09-25 Interim / Quarterly Rep…
Country CA Canada
Listing TSXV RCR.P

About Canna 8 Investment Trust

Canna 8 Investment Trust operates as a capital pool company (CPC). Its mandate is the identification and evaluation of prospective businesses or assets with the objective of completing a purchase transaction to acquire an interest therein. This process is designed to culminate in a Qualifying Transaction, consistent with the policies governing CPCs. The company utilized a trust structure for its initial public offering, aiming to provide potential tax, time, and cost efficiencies for its future acquisition activities.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report titled 'Condensed Interim Financial Statements' for Canna 8 Investment Trust for the three and six months ended June 30, 2025. It includes a Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Unitholder's Equity, Statement of Cash Flows, and detailed Notes to the Financial Statements. It is not an announcement or a summary, but the full interim financial report itself, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-25 English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109F2R “Certification of Refiled Interim Filings” under Canadian securities rules, certifying that the interim financial report and MD&A for the period ended June 30, 2025 have been reviewed and fairly presented. It is not the interim report itself, nor an AGM presentation, nor an earnings release or management discussion. It is a regulatory compliance certificate filed under NI 52-109 and does not fit any narrower category. Therefore it falls under the fallback category for miscellaneous regulatory filings.
2025-09-25 English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is Form 52-109F2R, a venture issuer basic certificate under Canadian National Instrument 52-109, certifying the refiled interim financial report and MD&A for the period ended June 30, 2025. It is a regulatory certification filing rather than the interim report itself, an earnings release, or any management discussion. There is no specific category for a certification form, so it falls under the general “Regulatory Filings” category (RNS).
2025-09-25 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 ‘Venture Issuer Basic Certificate’ providing the CFO’s certification of the interim financial report and interim MD&A for the period ended March 31, 2025. It is not the interim report itself (IR) nor an announcement of a report (RPA), but rather a compliance certification filing under securities legislation. It does not fit into any more specific category, so it is classified as a general regulatory filing (RNS).
2025-05-26 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” by the CEO of a venture issuer under NI 52-109. It does not contain the interim financial statements or MD&A itself, but is a standalone regulatory certificate required to be filed alongside the interim report. It is not the interim report (IR), nor an announcement of a report (RPA), but rather a specific compliance filing under securities legislation. Therefore it falls into the general Regulatory Filings category (RNS).
2025-05-26 English
Interim MD&A - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a detailed pricing supplement (“supplément de fixation du prix”) to a base prospectus, describing terms for a new issuance of medium‐term notes by CIBC (a structured note tied to UnitedHealth Group shares). It is not an earnings release, annual or interim report, call transcript or AGM material. Instead, it supports a fundraising/financing transaction (debt issuance) and therefore fits into the Capital/Financing Update category.
2025-05-26 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.